Who We Are
Health Technology & Regulatory Consultant - Medical Devices
Bryan is InViva’s COO and Principal consultant possessing a special interest in the development of medical devices and diagnostics, in particular the continual expansion of Software and AI as a Medical Device. However, this is just a small part of his interests and experience.
Describing himself as a ‘commercial scientist’, his 30 plus year career started after reading for a degree in Biology specialising in biotechnology and microbiology. His first role was as an auditor within the International Regulatory Department at ICI/AstraZenca Pharmaceuticals at Alderley Park, UK, working in Pre-clinical Quality Assurance on products such as Casodex, Nolvadex, Zoladex, Diprivan and meropenem. This led to commercial and regulatory roles within Novartis, Fresenius-Kabi, Alpha Therapeutic (USA) and Grupo Grifols (Spain). This encompassed pharmaceuticals, biologics, medical devices and in vitro diagnostics, and work that interfaced with the MHRA, the European Medicines Agency and the FDA.
After successfully completing both an MBA and CIM Diploma in Marketing, Bryan founded InViva as a sole trader in 2005, working with SMEs and academics wishing to translate their research into commercial products. This has led to nearly two decades of consulting uniting universities, SMEs, Blue Chip companies, funding bodies and investors to ‘make things happen’. A highlight was an invitation to meet the then deputy Prime Minister and members of the Cabinet of the UK Government, to discuss contribution that healthcare related technology was contributing to the regional economy, and how this could be grown further.
Having accumulated a deep understanding of what is required to commercialise new technologies, he cofounded a company with the University of Nottingham in 2015, leading to gaining an understanding of the UK’s regulation of Human Tissue products, working with the Human Tissue Authority to compile the Product Preparation Dossier and gain the necessary licences to process tissue as a regenerative therapy for both human and veterinary use. This was understood to be the first use instance of human tissue being used to treat animals, rather than vice versa.
Back home in Yorkshire, Bryan is one of the cofounders of InViva Healthcare Management Limited, and continues to support a multitude of companies from all the world to identify their needs and lead on solutions for commercialisation, regulatory affairs and Quality Management. He is a member of TOPRA, The Organisation for Professionals working in Regulatory Affairs, and works closely with the UK’s trade organisation for medical device manufacturers, Medilink.
Over 20 years’ experience in Business Development, Negotiation, Project Management, Procurement and Multi Site Management in the UK, Europe and Asia. World Wide contacts in the Pharmaceutical Industry.
Stakeholder management for complex manufacturing projects.
Strong leadership skills, and the ability to motivate a successful team
Commercial contract structuring
Business Case preparation to Board Level
Technical strategies for Pharmaceutical Manufacturing
Michael Li has worked in a variety of countries, including the United Kingdom, Malaysia, Laos, China, and Thailand, and has had the privilege of working with colleagues from diverse backgrounds and experiences, gaining valuable and unique knowledge along the way.
With a career spanning over a decade, he has consistently delivered outstanding results, earning a reputation for excellence and innovation in project management.
Michael Li began his career in project management after completing his education in Project Management at the University of Manchester. He quickly rose through the ranks, owing to his remarkable strategic thinking, attention to detail, and dedication to achieving project objectives.
Global Project Expertise:
Having managed projects across two diverse continents - Europe and Asia, Michael possesses a unique perspective on international project management. His extensive experience in these diverse regions has enabled him to navigate complex cultural, regulatory, and logistical challenges with finesse.
In Europe, he has successfully overseen projects for a wide range of industries, including healthcare and engineering, and consistently met stakeholder expectations. His ability to create cohesive, high-performing teams has been a key factor in the successful execution of projects in this dynamic market.
In Asia, Michael has shown a deep understanding of the region's business landscape, leveraging his network and multicultural awareness in Asian markets to facilitate the establishment of strong partnerships, resulting in a track record of delivering project objectives.
My motto is "simple is best" and "doing what makes sense."